Last reviewed · How we verify
NCT04572373
Supplements SMOF in TPN for Liver Transplantation Recipients
trial testing SMOFlipid in Liver Transplantation in 54 participants. Completed in 30 June 2015.
30 June 2015
Quick facts
| Lead sponsor | Chang Gung Memorial Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 54 |
| Start date | 1 January 2012 |
| Primary completion | 30 June 2015 |
| Estimated completion | 30 June 2015 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- SMOFlipid — full drug profile →
Conditions studied
- Liver Transplantation — all drugs for Liver Transplantation →
- Total Parenteral Nutrition — all drugs for Total Parenteral Nutrition →
- End-stage Liver Disease — all drugs for End-stage Liver Disease →
Sponsor
Chang Gung Memorial Hospital
Who can join
Adults 18 to 65, any sex, with Liver Transplantation or Total Parenteral Nutrition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Liver transplantation (LT) is one of the widely recognised and leading treatments for end-stage liver disease. Nutrition impacts its success. Total parenteral nutrition (TPN) is usually prescribed for patients recommended prolonged fasting after LT. The supplement of SMOFlipid (soybean oil, MCT oil, olive oil, and fish oil) is easily metabolised to produce energy, and it possesses anti-inflammatory effects; however, SMOFlipid emulsion use raises concerns regarding coagulopathy after LT. This study investigated the postoperative correlation between SMOFlipid and coagulation in LT.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation.
Wu MY, Kuo SC, Chuang SF, Yeh CH, et al · · 2021 · cited 1× · PMID 33664940 · DOI 10.1016/j.amsu.2021.01.042
Verify or expand the search:
- PubMed search for NCT04572373
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SMOFlipid
Trials testing the same drug.
- NCT04957940 — Lipid Emulsion Infusion and COVID-19 Patients · Phase 3 · completed
- NCT02412566 — SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury · approved for marketing
Other recruiting trials for Liver Transplantation
Currently open trials in the same condition.
- NCT07157631 — Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial · NA · recruiting
- NCT07123740 — Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors · NA · recruiting
- NCT06717919 — HOPE Against Cancer Recurrence in HCC · Phase 4 · recruiting
- NCT06868589 — Reducing Pain With Methadone and Ketamine in Liver Transplant · Phase 4 · active not recruiting
- NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
Other Chang Gung Memorial Hospital trials
Trials by the same sponsor.
- NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
- NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
- NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
- NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
- NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04572373 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
- Last refreshed: 8 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04572373.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing